PVI
SLDB icon

Pura Vida Investments’s Solid Biosciences SLDB Stock Holding History

Pura Vida Investments’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-224,902
Closed -$1.07M – 94
2023
Q1 		$1.07M Buy
+224,902
New +$1.35M 0.11% 65

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pura Vida Investments's SLDB Position: Q2 2023 in Review

Pura Vida Investments sold out of Solid Biosciences (SLDB) in Q2 2023, closing a stake of 224,902 shares — an estimated $1.07M sold.

Pura Vida Investments first reported a position in SLDB in Q1 2023 and held it in 1 quarter. The position peaked at $1.07M in Q1 2023. 36 funds tracked by Wall St. Rank hold SLDB as of Q2 2023.

  • Pura Vida Investments reported no remaining Solid Biosciences position as of Q2 2023 after selling out during the quarter.
  • Pura Vida Investments sold 224,902 Solid Biosciences shares in Q2 2023, an estimated $1.07M.
  • Pura Vida Investments first reported a position in Solid Biosciences in Q1 2023 and held it in 1 quarter.
  • Pura Vida Investments's Solid Biosciences position peaked at $1.07M in Q1 2023.
  • 36 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2023.

Based on Pura Vida Investments's 13F filing for Q2 2023, filed 14 Aug 2023.